Lee, Edward

Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome

Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., Lee, E. W., Burnett, M. S., Fricke, S. T., Kvetnansky, R., et al. (2007) · Nature Medicine

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 656

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study

Kontoyiannis, D. P., Yang, H., Song, J., Kelkar, S. S., Yang, X., Azie, N., Harrington, R., Fan, A., Lee, E., & Spalding, J. R. (2016) · BMC Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 132

Irreversible electroporation (NanoKnife) in cancer treatment

Jourabchi, N., Beroukhim, K., Tafti, B. A., Kee, S. T., & Lee, E. W. (2014) · Gastrointestinal Intervention

Microbial Inactivation MethodsAtmospheric-Pressure Plasma Applications

Cited by 99

Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab

Cai, C. X., Nishimura, A., Bowring, M. G., Westlund, E., Tran, D., Ng, J. H., Nagy, P., Cook, M., McLeggon, J.-A., DuVall, S. L., et al. (2024) · Ophthalmology Retina

Retinal Diseases and TreatmentsDrug-Induced Ocular Toxicity

Cited by 20

A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects

Trivedi, A., Mather, O., Vega, S., Hutton, S., Hellawell, J., & Lee, E. (2022) · Drugs in R&D

Apelin-related biomedical researchHeart Failure Treatment and Management

Cited by 10